ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasma Derived Medicine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-34W7280
Home | Market Reports | Health| Pharmacy
Global Plasma Derived Medicine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Plasma Derived Medicine Market Research Report 2024

Code: QYRE-Auto-34W7280
Report
January 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
Biotest
Octapharma AG
CSL Limited
BPL
China Biologic Products
Boya Bio-pharmaceutical
Takeda
Kedrion S p A
LFB Group
Shanghai Raas
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd

Plasma Derived Medicine Market Size

The global Plasma Derived Medicine market was valued at US$ 2291.1 million in 2023 and is anticipated to reach US$ 3847.1 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.

Plasma Derived Medicine Market

Plasma Derived Medicine Market

Plasma Derived Medicine is any therapeutic substance prepared from human blood.
North American market for Plasma Derived Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Plasma Derived Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Plasma Derived Medicine include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and Shanghai RAAS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasma Derived Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Derived Medicine.

Report Scope

The Plasma Derived Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Derived Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Derived Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Plasma Derived Medicine Market Report

Report Metric Details
Report Name Plasma Derived Medicine Market
Accounted market size in 2023 US$ 2291.1 million
Forecasted market size in 2030 US$ 3847.1 million
CAGR 7.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Others
Segment by Application
  • Bleeding Wound
  • Immunodeficiency
  • HBV
  • Tetanus
  • Rabies
  • Hemophilia
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, Shanghai RAAS, China Biologic Products, Hualan Biological Engineering Inc., Beijing Tiantan Biological Products Corp, Pacific Shuanglin, Boya Bio-Pharmaceutical, Paisi Feike Biology Pharmacy Co., Ltd., Xinjiang Deyuan Bioengineering, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Shenzhen Weiguang, Shanxi Kangbao, Nanyue Biopharming Corporation Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Plasma Derived Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Plasma Derived Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Plasma Derived Medicine Market growing?

Ans: The Plasma Derived Medicine Market witnessing a CAGR of 7.8% during the forecast period 2024-2030.

What is the Plasma Derived Medicine Market size in 2030?

Ans: The Plasma Derived Medicine Market size in 2030 will be US$ 3847.1 million.

Who are the main players in the Plasma Derived Medicine Market report?

Ans: The main players in the Plasma Derived Medicine Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, Shanghai RAAS, China Biologic Products, Hualan Biological Engineering Inc., Beijing Tiantan Biological Products Corp, Pacific Shuanglin, Boya Bio-Pharmaceutical, Paisi Feike Biology Pharmacy Co., Ltd., Xinjiang Deyuan Bioengineering, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Shenzhen Weiguang, Shanxi Kangbao, Nanyue Biopharming Corporation Ltd

What are the Application segmentation covered in the Plasma Derived Medicine Market report?

Ans: The Applications covered in the Plasma Derived Medicine Market report are Bleeding Wound, Immunodeficiency, HBV, Tetanus, Rabies, Hemophilia, Others

What are the Type segmentation covered in the Plasma Derived Medicine Market report?

Ans: The Types covered in the Plasma Derived Medicine Market report are Albumin, Immune Globulin, Coagulation Factor, Others

1 Plasma Derived Medicine Market Overview
1.1 Product Overview and Scope of Plasma Derived Medicine
1.2 Plasma Derived Medicine Segment by Type
1.2.1 Global Plasma Derived Medicine Market Value Comparison by Type (2024-2030)
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.2.5 Others
1.3 Plasma Derived Medicine Segment by Application
1.3.1 Global Plasma Derived Medicine Market Value by Application: (2024-2030)
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Global Plasma Derived Medicine Market Size Estimates and Forecasts
1.4.1 Global Plasma Derived Medicine Revenue 2019-2030
1.4.2 Global Plasma Derived Medicine Sales 2019-2030
1.4.3 Global Plasma Derived Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Plasma Derived Medicine Market Competition by Manufacturers
2.1 Global Plasma Derived Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Plasma Derived Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Plasma Derived Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Plasma Derived Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma Derived Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Derived Medicine, Product Type & Application
2.7 Plasma Derived Medicine Market Competitive Situation and Trends
2.7.1 Plasma Derived Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma Derived Medicine Players Market Share by Revenue
2.7.3 Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma Derived Medicine Retrospective Market Scenario by Region
3.1 Global Plasma Derived Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Plasma Derived Medicine Global Plasma Derived Medicine Sales by Region: 2019-2030
3.2.1 Global Plasma Derived Medicine Sales by Region: 2019-2024
3.2.2 Global Plasma Derived Medicine Sales by Region: 2025-2030
3.3 Global Plasma Derived Medicine Global Plasma Derived Medicine Revenue by Region: 2019-2030
3.3.1 Global Plasma Derived Medicine Revenue by Region: 2019-2024
3.3.2 Global Plasma Derived Medicine Revenue by Region: 2025-2030
3.4 North America Plasma Derived Medicine Market Facts & Figures by Country
3.4.1 North America Plasma Derived Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Plasma Derived Medicine Sales by Country (2019-2030)
3.4.3 North America Plasma Derived Medicine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Plasma Derived Medicine Market Facts & Figures by Country
3.5.1 Europe Plasma Derived Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Plasma Derived Medicine Sales by Country (2019-2030)
3.5.3 Europe Plasma Derived Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Derived Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma Derived Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Plasma Derived Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Plasma Derived Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Plasma Derived Medicine Market Facts & Figures by Country
3.7.1 Latin America Plasma Derived Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Plasma Derived Medicine Sales by Country (2019-2030)
3.7.3 Latin America Plasma Derived Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Plasma Derived Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Derived Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Plasma Derived Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Plasma Derived Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasma Derived Medicine Sales by Type (2019-2030)
4.1.1 Global Plasma Derived Medicine Sales by Type (2019-2024)
4.1.2 Global Plasma Derived Medicine Sales by Type (2025-2030)
4.1.3 Global Plasma Derived Medicine Sales Market Share by Type (2019-2030)
4.2 Global Plasma Derived Medicine Revenue by Type (2019-2030)
4.2.1 Global Plasma Derived Medicine Revenue by Type (2019-2024)
4.2.2 Global Plasma Derived Medicine Revenue by Type (2025-2030)
4.2.3 Global Plasma Derived Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Plasma Derived Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Plasma Derived Medicine Sales by Application (2019-2030)
5.1.1 Global Plasma Derived Medicine Sales by Application (2019-2024)
5.1.2 Global Plasma Derived Medicine Sales by Application (2025-2030)
5.1.3 Global Plasma Derived Medicine Sales Market Share by Application (2019-2030)
5.2 Global Plasma Derived Medicine Revenue by Application (2019-2030)
5.2.1 Global Plasma Derived Medicine Revenue by Application (2019-2024)
5.2.2 Global Plasma Derived Medicine Revenue by Application (2025-2030)
5.2.3 Global Plasma Derived Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Plasma Derived Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Plasma Derived Medicine Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Plasma Derived Medicine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Plasma Derived Medicine Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Plasma Derived Medicine Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Plasma Derived Medicine Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LFB Group Plasma Derived Medicine Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotest Plasma Derived Medicine Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BPL Plasma Derived Medicine Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai RAAS Plasma Derived Medicine Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 China Biologic Products
6.10.1 China Biologic Products Corporation Information
6.10.2 China Biologic Products Description and Business Overview
6.10.3 China Biologic Products Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 China Biologic Products Plasma Derived Medicine Product Portfolio
6.10.5 China Biologic Products Recent Developments/Updates
6.11 Hualan Biological Engineering Inc.
6.11.1 Hualan Biological Engineering Inc. Corporation Information
6.11.2 Hualan Biological Engineering Inc. Plasma Derived Medicine Description and Business Overview
6.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Portfolio
6.11.5 Hualan Biological Engineering Inc. Recent Developments/Updates
6.12 Beijing Tiantan Biological Products Corp
6.12.1 Beijing Tiantan Biological Products Corp Corporation Information
6.12.2 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Description and Business Overview
6.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Portfolio
6.12.5 Beijing Tiantan Biological Products Corp Recent Developments/Updates
6.13 Pacific Shuanglin
6.13.1 Pacific Shuanglin Corporation Information
6.13.2 Pacific Shuanglin Plasma Derived Medicine Description and Business Overview
6.13.3 Pacific Shuanglin Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Pacific Shuanglin Plasma Derived Medicine Product Portfolio
6.13.5 Pacific Shuanglin Recent Developments/Updates
6.14 Boya Bio-Pharmaceutical
6.14.1 Boya Bio-Pharmaceutical Corporation Information
6.14.2 Boya Bio-Pharmaceutical Plasma Derived Medicine Description and Business Overview
6.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Portfolio
6.14.5 Boya Bio-Pharmaceutical Recent Developments/Updates
6.15 Paisi Feike Biology Pharmacy Co., Ltd.
6.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
6.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Description and Business Overview
6.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Portfolio
6.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
6.16 Xinjiang Deyuan Bioengineering
6.16.1 Xinjiang Deyuan Bioengineering Corporation Information
6.16.2 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Description and Business Overview
6.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Portfolio
6.16.5 Xinjiang Deyuan Bioengineering Recent Developments/Updates
6.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
6.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
6.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Description and Business Overview
6.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Portfolio
6.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.18 Shenzhen Weiguang
6.18.1 Shenzhen Weiguang Corporation Information
6.18.2 Shenzhen Weiguang Plasma Derived Medicine Description and Business Overview
6.18.3 Shenzhen Weiguang Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shenzhen Weiguang Plasma Derived Medicine Product Portfolio
6.18.5 Shenzhen Weiguang Recent Developments/Updates
6.19 Shanxi Kangbao
6.19.1 Shanxi Kangbao Corporation Information
6.19.2 Shanxi Kangbao Plasma Derived Medicine Description and Business Overview
6.19.3 Shanxi Kangbao Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shanxi Kangbao Plasma Derived Medicine Product Portfolio
6.19.5 Shanxi Kangbao Recent Developments/Updates
6.20 Nanyue Biopharming Corporation Ltd
6.20.1 Nanyue Biopharming Corporation Ltd Corporation Information
6.20.2 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Description and Business Overview
6.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Portfolio
6.20.5 Nanyue Biopharming Corporation Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Derived Medicine Industry Chain Analysis
7.2 Plasma Derived Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Derived Medicine Production Mode & Process
7.4 Plasma Derived Medicine Sales and Marketing
7.4.1 Plasma Derived Medicine Sales Channels
7.4.2 Plasma Derived Medicine Distributors
7.5 Plasma Derived Medicine Customers
8 Plasma Derived Medicine Market Dynamics
8.1 Plasma Derived Medicine Industry Trends
8.2 Plasma Derived Medicine Market Drivers
8.3 Plasma Derived Medicine Market Challenges
8.4 Plasma Derived Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Grifols S A
Biotest
Octapharma AG
CSL Limited
BPL
China Biologic Products
Boya Bio-pharmaceutical
Takeda
Kedrion S p A
LFB Group
Shanghai Raas
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
List of Tables
    Table 1. Global Plasma Derived Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Plasma Derived Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Plasma Derived Medicine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Plasma Derived Medicine Sales (K Bottles) of Key Manufacturers (2019-2024)
    Table 5. Global Plasma Derived Medicine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Plasma Derived Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Plasma Derived Medicine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Plasma Derived Medicine Average Price (USD/Bottle) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Plasma Derived Medicine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Plasma Derived Medicine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Plasma Derived Medicine, Product Type & Application
    Table 12. Global Key Manufacturers of Plasma Derived Medicine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Plasma Derived Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Plasma Derived Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Plasma Derived Medicine Sales by Region (2019-2024) & (K Bottles)
    Table 18. Global Plasma Derived Medicine Sales Market Share by Region (2019-2024)
    Table 19. Global Plasma Derived Medicine Sales by Region (2025-2030) & (K Bottles)
    Table 20. Global Plasma Derived Medicine Sales Market Share by Region (2025-2030)
    Table 21. Global Plasma Derived Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Plasma Derived Medicine Revenue Market Share by Region (2019-2024)
    Table 23. Global Plasma Derived Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Plasma Derived Medicine Revenue Market Share by Region (2025-2030)
    Table 25. North America Plasma Derived Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
    Table 27. North America Plasma Derived Medicine Sales by Country (2025-2030) & (K Bottles)
    Table 28. North America Plasma Derived Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Plasma Derived Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Plasma Derived Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
    Table 32. Europe Plasma Derived Medicine Sales by Country (2025-2030) & (K Bottles)
    Table 33. Europe Plasma Derived Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Plasma Derived Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Plasma Derived Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Plasma Derived Medicine Sales by Region (2019-2024) & (K Bottles)
    Table 37. Asia Pacific Plasma Derived Medicine Sales by Region (2025-2030) & (K Bottles)
    Table 38. Asia Pacific Plasma Derived Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Plasma Derived Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Plasma Derived Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
    Table 42. Latin America Plasma Derived Medicine Sales by Country (2025-2030) & (K Bottles)
    Table 43. Latin America Plasma Derived Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Plasma Derived Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Plasma Derived Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Plasma Derived Medicine Sales by Country (2019-2024) & (K Bottles)
    Table 47. Middle East & Africa Plasma Derived Medicine Sales by Country (2025-2030) & (K Bottles)
    Table 48. Middle East & Africa Plasma Derived Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Plasma Derived Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Plasma Derived Medicine Sales (K Bottles) by Type (2019-2024)
    Table 51. Global Plasma Derived Medicine Sales (K Bottles) by Type (2025-2030)
    Table 52. Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
    Table 53. Global Plasma Derived Medicine Sales Market Share by Type (2025-2030)
    Table 54. Global Plasma Derived Medicine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Plasma Derived Medicine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Plasma Derived Medicine Revenue Market Share by Type (2019-2024)
    Table 57. Global Plasma Derived Medicine Revenue Market Share by Type (2025-2030)
    Table 58. Global Plasma Derived Medicine Price (USD/Bottle) by Type (2019-2024)
    Table 59. Global Plasma Derived Medicine Price (USD/Bottle) by Type (2025-2030)
    Table 60. Global Plasma Derived Medicine Sales (K Bottles) by Application (2019-2024)
    Table 61. Global Plasma Derived Medicine Sales (K Bottles) by Application (2025-2030)
    Table 62. Global Plasma Derived Medicine Sales Market Share by Application (2019-2024)
    Table 63. Global Plasma Derived Medicine Sales Market Share by Application (2025-2030)
    Table 64. Global Plasma Derived Medicine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Plasma Derived Medicine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Plasma Derived Medicine Revenue Market Share by Application (2019-2024)
    Table 67. Global Plasma Derived Medicine Revenue Market Share by Application (2025-2030)
    Table 68. Global Plasma Derived Medicine Price (USD/Bottle) by Application (2019-2024)
    Table 69. Global Plasma Derived Medicine Price (USD/Bottle) by Application (2025-2030)
    Table 70. Takeda Corporation Information
    Table 71. Takeda Description and Business Overview
    Table 72. Takeda Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 73. Takeda Plasma Derived Medicine Product
    Table 74. Takeda Recent Developments/Updates
    Table 75. CSL Corporation Information
    Table 76. CSL Description and Business Overview
    Table 77. CSL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 78. CSL Plasma Derived Medicine Product
    Table 79. CSL Recent Developments/Updates
    Table 80. Grifols Corporation Information
    Table 81. Grifols Description and Business Overview
    Table 82. Grifols Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 83. Grifols Plasma Derived Medicine Product
    Table 84. Grifols Recent Developments/Updates
    Table 85. Octapharma Corporation Information
    Table 86. Octapharma Description and Business Overview
    Table 87. Octapharma Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 88. Octapharma Plasma Derived Medicine Product
    Table 89. Octapharma Recent Developments/Updates
    Table 90. Kedrion Corporation Information
    Table 91. Kedrion Description and Business Overview
    Table 92. Kedrion Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 93. Kedrion Plasma Derived Medicine Product
    Table 94. Kedrion Recent Developments/Updates
    Table 95. LFB Group Corporation Information
    Table 96. LFB Group Description and Business Overview
    Table 97. LFB Group Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 98. LFB Group Plasma Derived Medicine Product
    Table 99. LFB Group Recent Developments/Updates
    Table 100. Biotest Corporation Information
    Table 101. Biotest Description and Business Overview
    Table 102. Biotest Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 103. Biotest Plasma Derived Medicine Product
    Table 104. Biotest Recent Developments/Updates
    Table 105. BPL Corporation Information
    Table 106. BPL Description and Business Overview
    Table 107. BPL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 108. BPL Plasma Derived Medicine Product
    Table 109. BPL Recent Developments/Updates
    Table 110. Shanghai RAAS Corporation Information
    Table 111. Shanghai RAAS Description and Business Overview
    Table 112. Shanghai RAAS Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 113. Shanghai RAAS Plasma Derived Medicine Product
    Table 114. Shanghai RAAS Recent Developments/Updates
    Table 115. China Biologic Products Corporation Information
    Table 116. China Biologic Products Description and Business Overview
    Table 117. China Biologic Products Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 118. China Biologic Products Plasma Derived Medicine Product
    Table 119. China Biologic Products Recent Developments/Updates
    Table 120. Hualan Biological Engineering Inc. Corporation Information
    Table 121. Hualan Biological Engineering Inc. Description and Business Overview
    Table 122. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 123. Hualan Biological Engineering Inc. Plasma Derived Medicine Product
    Table 124. Hualan Biological Engineering Inc. Recent Developments/Updates
    Table 125. Beijing Tiantan Biological Products Corp Corporation Information
    Table 126. Beijing Tiantan Biological Products Corp Description and Business Overview
    Table 127. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 128. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product
    Table 129. Beijing Tiantan Biological Products Corp Recent Developments/Updates
    Table 130. Pacific Shuanglin Corporation Information
    Table 131. Pacific Shuanglin Description and Business Overview
    Table 132. Pacific Shuanglin Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 133. Pacific Shuanglin Plasma Derived Medicine Product
    Table 134. Pacific Shuanglin Recent Developments/Updates
    Table 135. Boya Bio-Pharmaceutical Corporation Information
    Table 136. Boya Bio-Pharmaceutical Description and Business Overview
    Table 137. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 138. Boya Bio-Pharmaceutical Plasma Derived Medicine Product
    Table 139. Boya Bio-Pharmaceutical Recent Developments/Updates
    Table 140. Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
    Table 141. Paisi Feike Biology Pharmacy Co., Ltd. Description and Business Overview
    Table 142. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 143. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product
    Table 144. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
    Table 145. Xinjiang Deyuan Bioengineering Corporation Information
    Table 146. Xinjiang Deyuan Bioengineering Description and Business Overview
    Table 147. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 148. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product
    Table 149. Xinjiang Deyuan Bioengineering Recent Developments/Updates
    Table 150. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
    Table 151. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description and Business Overview
    Table 152. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 153. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product
    Table 154. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
    Table 155. Shenzhen Weiguang Corporation Information
    Table 156. Shenzhen Weiguang Description and Business Overview
    Table 157. Shenzhen Weiguang Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 158. Shenzhen Weiguang Plasma Derived Medicine Product
    Table 159. Shenzhen Weiguang Recent Developments/Updates
    Table 160. Shanxi Kangbao Corporation Information
    Table 161. Shanxi Kangbao Description and Business Overview
    Table 162. Shanxi Kangbao Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 163. Shanxi Kangbao Plasma Derived Medicine Product
    Table 164. Shanxi Kangbao Recent Developments/Updates
    Table 165. Nanyue Biopharming Corporation Ltd Corporation Information
    Table 166. Nanyue Biopharming Corporation Ltd Description and Business Overview
    Table 167. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
    Table 168. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product
    Table 169. Nanyue Biopharming Corporation Ltd Recent Developments/Updates
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Plasma Derived Medicine Distributors List
    Table 173. Plasma Derived Medicine Customers List
    Table 174. Plasma Derived Medicine Market Trends
    Table 175. Plasma Derived Medicine Market Drivers
    Table 176. Plasma Derived Medicine Market Challenges
    Table 177. Plasma Derived Medicine Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Plasma Derived Medicine
    Figure 2. Global Plasma Derived Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Plasma Derived Medicine Market Share by Type in 2023 & 2030
    Figure 4. Albumin Product Picture
    Figure 5. Immune Globulin Product Picture
    Figure 6. Coagulation Factor Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Plasma Derived Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Plasma Derived Medicine Market Share by Application in 2023 & 2030
    Figure 10. Bleeding Wound
    Figure 11. Immunodeficiency
    Figure 12. HBV
    Figure 13. Tetanus
    Figure 14. Rabies
    Figure 15. Hemophilia
    Figure 16. Others
    Figure 17. Global Plasma Derived Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Plasma Derived Medicine Market Size (2019-2030) & (US$ Million)
    Figure 19. Global Plasma Derived Medicine Sales (2019-2030) & (K Bottles)
    Figure 20. Global Plasma Derived Medicine Average Price (USD/Bottle) & (2019-2030)
    Figure 21. Plasma Derived Medicine Report Years Considered
    Figure 22. Plasma Derived Medicine Sales Share by Manufacturers in 2023
    Figure 23. Global Plasma Derived Medicine Revenue Share by Manufacturers in 2023
    Figure 24. The Global 5 and 10 Largest Plasma Derived Medicine Players: Market Share by Revenue in 2023
    Figure 25. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 26. Global Plasma Derived Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 27. North America Plasma Derived Medicine Sales Market Share by Country (2019-2030)
    Figure 28. North America Plasma Derived Medicine Revenue Market Share by Country (2019-2030)
    Figure 29. United States Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Canada Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Mexico Plasma Derived Medicine Revenue Growth Rate (2019-2024) & (US$ Million)
    Figure 32. Europe Plasma Derived Medicine Sales Market Share by Country (2019-2030)
    Figure 33. Europe Plasma Derived Medicine Revenue Market Share by Country (2019-2030)
    Figure 34. Germany Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. France Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. UK Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Italy Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Russia Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Asia Pacific Plasma Derived Medicine Sales Market Share by Region (2019-2030)
    Figure 40. Asia Pacific Plasma Derived Medicine Revenue Market Share by Region (2019-2030)
    Figure 41. China Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Japan Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. South Korea Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. India Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Australia Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Indonesia Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Thailand Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Malaysia Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Philippines Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Vietnam Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Latin America Plasma Derived Medicine Sales Market Share by Country (2019-2030)
    Figure 52. Latin America Plasma Derived Medicine Revenue Market Share by Country (2019-2030)
    Figure 53. Mexico Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Brazil Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Argentina Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Colombia Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country (2019-2030)
    Figure 58. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country (2019-2030)
    Figure 59. Turkey Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 60. Saudi Arabia Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 61. UAE Plasma Derived Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 62. Global Sales Market Share of Plasma Derived Medicine by Type (2019-2030)
    Figure 63. Global Revenue Market Share of Plasma Derived Medicine by Type (2019-2030)
    Figure 64. Global Plasma Derived Medicine Price (USD/Bottle) by Type (2019-2030)
    Figure 65. Global Sales Market Share of Plasma Derived Medicine by Application (2019-2030)
    Figure 66. Global Revenue Market Share of Plasma Derived Medicine by Application (2019-2030)
    Figure 67. Global Plasma Derived Medicine Price (USD/Bottle) by Application (2019-2030)
    Figure 68. Plasma Derived Medicine Value Chain
    Figure 69. Plasma Derived Medicine Production Process
    Figure 70. Channels of Distribution (Direct Vs Distribution)
    Figure 71. Distributors Profiles
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions